Jie Mei

11PUBLICATIONS
17CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 12, 2025
Targeting B7-H3 inhibition-induced activation of fatty acid synthesis boosts anti-B7-H3 immunotherapy in triple-negative breast cancer.

Ying Jiang, Zhiwen Qian, Cenzhu Wang

|Sep 07, 2024
Angiotensin receptor blocker attacks armored and cold tumors and boosts immune checkpoint blockade.

Jie Mei, Jiahui Chu, Kai Yang

|Mar 20, 2024
Conserved immuno-collagenic subtypes predict response to immune checkpoint blockade.

Jie Mei, Yun Cai, Rui Xu

|Sep 12, 2022
Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer.

Jinlu Zhao, Jie Mei, Fengxu Wang

|Mar 04, 2022
Biochanin A Suppresses Tumor Progression and PD-L1 Expression via Inhibiting ZEB1 Expression in Colorectal Cancer.

Junying Xu, Xuejing Yang, Jiadong Pan

|Mar 17, 2021
Osthole Inhibits Breast Cancer Progression through Upregulating Tumor Suppressor GNG7.

Jie Mei, Tiejun Wang, Shaojie Zhao

Pageof 2

Frequent Collaborators

4 joint publications

Yan Zhang

1 joint publications

Chaoying Liu

1 joint publications

Rui Xu

1 joint publications

Jiadong Pan